New psoriatic arthritis screening tool passes initial validationApril 17, 2015Psoriatic ArthritisPsoriasis
Ixekizumab met psoriasis endpoints by week 12, with durable response at 60 weeksApril 9, 2015PsoriasisPsoriatic Arthritis
Methotrexate and biologics linked to higher zoster risk in psoriasisMarch 22, 2015PsoriasisPsoriatic Arthritis
Secukinumab beat ustekinumab for psoriasis, with difference by week fourMarch 21, 2015PsoriasisPsoriatic Arthritis
Brodalumab achieved primary endpoints for moderate to severe psoriasis at 52 weeksMarch 21, 2015PsoriasisPsoriatic Arthritis
Halting biologics before surgery tied to flares in psoriasis, psoriatic arthritisMarch 13, 2015Psoriatic ArthritisPsoriasis
Interleukin-23 inhibition with tildrakizumab achieves significant psoriasis improvementsMarch 9, 2015PsoriasisPsoriatic Arthritis
